• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

偶然分枝杆菌和龟分枝杆菌对抗菌剂敏感性的纸片扩散试验

Disk diffusion testing of susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to antibacterial agents.

作者信息

Wallace R J, Dalovisio J R, Pankey G A

出版信息

Antimicrob Agents Chemother. 1979 Nov;16(5):611-4. doi: 10.1128/AAC.16.5.611.

DOI:10.1128/AAC.16.5.611
PMID:526002
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC352914/
Abstract

Although recent studies have suggested that some antibacterial agents have good activity against the rapidly growing mycobacteria Mycobacterium fortuitum and Mycobacterium chelonei, an easily applicable method for susceptibility testing of clinical isolates is not yet available. We evaluated a disk diffusion method with Mueller-Hinton agar and 48-h readings with 59 strains of M. fortuitum and 11 strains of M. chelonei and compared the results to agar dilution susceptibilities for nine antimicrobial agents. All isolates were susceptible to 16 micrograms of amikacin or kanamycin per ml with minimum zone diameters of 14 and 18 mm, respectively. Amikacin inhibited 100% of isolates of M. fortuitum at 2 micrograms/ml, whereas 10 of 11 (91%) of M. chelonei strains had minimum inhibitory concentrations of 4.0 micrograms/ml or greater. Doxycycline and minocycline had almost identical activities, inhibiting 44% of strains at 4.0 micrograms/ml, and both allowed easy differentiation between susceptible and resistant strains by disk diffusion. Although most isolates of M. chelonei grew better on 7H10 agar, this media gave two- to eight-fold higher minimum inhibitory concentrations than were obtained with Mueller-Hinton agar. Disk diffusion susceptibility testing appears to be a simple and reliable means of predicting susceptibility results for M. fortuitum and most isolates of M. chelonei by the agar dilution method.

摘要

尽管最近的研究表明,一些抗菌剂对快速生长的偶然分枝杆菌和龟分枝杆菌具有良好的活性,但目前仍没有一种易于应用的临床分离株药敏试验方法。我们评估了用穆勒-欣顿琼脂的纸片扩散法,并对59株偶然分枝杆菌和11株龟分枝杆菌进行了48小时读数,将结果与9种抗菌剂的琼脂稀释药敏结果进行了比较。所有分离株对每毫升16微克的阿米卡星或卡那霉素敏感,最小抑菌圈直径分别为14毫米和18毫米。阿米卡星在2微克/毫升时抑制了100%的偶然分枝杆菌分离株,而11株龟分枝杆菌中有10株(91%)的最小抑菌浓度为4.0微克/毫升或更高。多西环素和米诺环素具有几乎相同的活性,在4.0微克/毫升时抑制了44%的菌株,并且两者都能通过纸片扩散法轻松区分敏感菌株和耐药菌株。尽管大多数龟分枝杆菌分离株在7H10琼脂上生长得更好,但这种培养基的最小抑菌浓度比穆勒-欣顿琼脂高2至8倍。纸片扩散药敏试验似乎是一种简单可靠的方法,可通过琼脂稀释法预测偶然分枝杆菌和大多数龟分枝杆菌分离株的药敏结果。

相似文献

1
Disk diffusion testing of susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to antibacterial agents.偶然分枝杆菌和龟分枝杆菌对抗菌剂敏感性的纸片扩散试验
Antimicrob Agents Chemother. 1979 Nov;16(5):611-4. doi: 10.1128/AAC.16.5.611.
2
Agar disk elution method for susceptibility testing of Mycobacterium marinum and Mycobacterium fortuitum complex to sulfonamides and antibiotics.用于海分枝杆菌和偶然分枝杆菌复合群对磺胺类药物及抗生素药敏试验的琼脂纸片洗脱法
Antimicrob Agents Chemother. 1983 Oct;24(4):486-93. doi: 10.1128/AAC.24.4.486.
3
Antimicrobial susceptibility testing of Mycobacterium fortuitum complex.偶然分枝杆菌复合体的药敏试验
Antimicrob Agents Chemother. 1979 Jun;15(6):754-7. doi: 10.1128/AAC.15.6.754.
4
Rapidly growing mycobacteria: testing of susceptibility to 34 antimicrobial agents by broth microdilution.快速生长分枝杆菌:采用肉汤微量稀释法检测对34种抗菌药物的敏感性
Antimicrob Agents Chemother. 1982 Aug;22(2):186-92. doi: 10.1128/AAC.22.2.186.
5
Disk diffusion testing with polymyxin and amikacin for differentiation of Mycobacterium fortuitum and Mycobacterium chelonei.使用多粘菌素和阿米卡星进行纸片扩散试验以区分偶然分枝杆菌和龟分枝杆菌。
J Clin Microbiol. 1982 Dec;16(6):1003-6. doi: 10.1128/jcm.16.6.1003-1006.1982.
6
Activity of amikacin, erythromycin and doxycyline against Mycobacterium chelonei and Mycobacterium fortuitum.阿米卡星、红霉素和强力霉素对龟分枝杆菌和偶然分枝杆菌的活性。
Tubercle. 1978 Dec;59(4):277-80. doi: 10.1016/0041-3879(78)90005-3.
7
Sulfonamide activity against Mycobacterium fortuitum and Mycobacterium chelonei.磺胺对偶然分枝杆菌和龟分枝杆菌的活性。
Rev Infect Dis. 1981 Sep-Oct;3(5):898-904. doi: 10.1093/clinids/3.5.898.
8
In vitro antimicrobial susceptibility testing of rapidly growing mycobacteria using the tablet diffusion method: resistance pattern of Norwegian Mycobacterium fortuitum and Mycobacterium chelonae isolates.采用纸片扩散法对快速生长分枝杆菌进行体外抗菌药敏试验:挪威偶然分枝杆菌和龟分枝杆菌分离株的耐药模式
APMIS. 1993 Jan;101(1):27-32.
9
Mutational resistance as the mechanism of acquired drug resistance to aminoglycosides and antibacterial agents in Mycobacterium fortuitum and Mycobacterium chelonei. Evidence is based on plasmid analysis, mutational frequencies, and aminoglycoside-modifying enzyme assays.突变抗性作为偶然分枝杆菌和龟分枝杆菌对氨基糖苷类及抗菌药物获得性耐药的机制。证据基于质粒分析、突变频率和氨基糖苷类修饰酶检测。
Am Rev Respir Dis. 1985 Aug;132(2):409-16. doi: 10.1164/arrd.1985.132.2.409.
10
In vitro susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to cefmetazole.偶然分枝杆菌和龟分枝杆菌对头孢美唑的体外敏感性
Antimicrob Agents Chemother. 1985 Feb;27(2):282-3. doi: 10.1128/AAC.27.2.282.

引用本文的文献

1
Design, synthesis, and computational analysis (molecular docking, DFT, MEP, RDG, ELF) of diazepine and oxazepine sulfonamides: biological evaluation for in vitro and in vivo anti-inflammatory, antimicrobial, and cytotoxicity predictions.二氮杂䓬和恶唑䓬磺酰胺的设计、合成及计算分析(分子对接、密度泛函理论、分子静电势、分子中的原子理论、电子定域函数):体外和体内抗炎、抗菌及细胞毒性预测的生物学评价
Mol Divers. 2025 Jun;29(3):2367-2389. doi: 10.1007/s11030-024-10996-5. Epub 2024 Oct 2.
2
A synergistic investigation of azo-thiazole derivatives incorporating thiazole moieties: a comprehensive exploration of their synthesis, characterization, computational insights, solvatochromism, and multimodal biological activity assessment.含噻唑部分的偶氮-噻唑衍生物的协同研究:对其合成、表征、计算分析、溶剂化显色以及多模式生物活性评估的全面探索
RSC Adv. 2023 Nov 24;13(49):34534-34555. doi: 10.1039/d3ra06469g. eCollection 2023 Nov 22.
3
Review of methods for detection and characterization of non-tuberculous mycobacteria in aquatic organisms.水生生物中非结核分枝杆菌的检测和鉴定方法综述。
J Vet Diagn Invest. 2024 May;36(3):299-311. doi: 10.1177/10406387231194619. Epub 2023 Aug 22.
4
Evolution of Antibacterial Drug Screening Methods: Current Prospects for Mycobacteria.抗菌药物筛选方法的演变:分枝杆菌的当前前景
Microorganisms. 2021 Dec 10;9(12):2562. doi: 10.3390/microorganisms9122562.
5
Drug Resistance in Nontuberculous Mycobacteria: Mechanisms and Models.非结核分枝杆菌中的耐药性:机制与模型
Biology (Basel). 2021 Jan 29;10(2):96. doi: 10.3390/biology10020096.
6
Real time PCR for the rapid identification and drug susceptibility of Mycobacteria present in Bronchial washings.用于快速鉴定支气管灌洗物中分枝杆菌并检测其药敏性的实时聚合酶链反应
BMC Infect Dis. 2016 Oct 26;16(1):607. doi: 10.1186/s12879-016-1943-y.
7
Mycobacterium chelonae abscesses associated with biomesotherapy, Australia, 2008.2008 年澳大利亚与生物疗法相关的脓肿分枝杆菌感染。
Emerg Infect Dis. 2013;19(9):1493-5. doi: 10.3201/eid1909.120898.
8
Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.非结核分枝杆菌感染的抗菌药物敏感性试验、耐药机制及治疗。
Clin Microbiol Rev. 2012 Jul;25(3):545-82. doi: 10.1128/CMR.05030-11.
9
Tetracycline resistance and presence of tetracycline resistance determinants tet(V) and tap in rapidly growing mycobacteria from agricultural soils and clinical isolates.四环素耐药性及快速生长分枝杆菌中四环素耐药决定因子 tet(V) 和 tap 在农业土壤和临床分离株中的存在。
Microbes Environ. 2012;27(4):413-22. doi: 10.1264/jsme2.me12028. Epub 2012 May 17.
10
Characterization of the Mycobacterium tuberculosis sigma factor SigM by assessment of virulence and identification of SigM-dependent genes.通过评估毒力和鉴定SigM依赖性基因对结核分枝杆菌σ因子SigM进行表征。
Infect Immun. 2007 Jan;75(1):452-61. doi: 10.1128/IAI.01395-06. Epub 2006 Nov 6.

本文引用的文献

1
In-vitro activity of erythromycin against atypical mycobacteria.
J Infect Dis. 1971 Feb;123(2):216-9. doi: 10.1093/infdis/123.2.216.
2
Clinical significance of Mycobacterium fortuitum infections in pulmonary disease.偶然分枝杆菌肺部感染的临床意义
Am Rev Respir Dis. 1973 Nov;108(5):1230-4. doi: 10.1164/arrd.1973.108.5.1230.
3
Susceptibility of organisms in the Mycobacterium fortuitum complex to antituberculous and other antimicrobial agents.偶然分枝杆菌复合群中各微生物对抗结核及其他抗菌药物的敏感性。
Antimicrob Agents Chemother. 1977 Aug;12(2):295-7. doi: 10.1128/AAC.12.2.295.
4
Activity of amikacin, erythromycin and doxycyline against Mycobacterium chelonei and Mycobacterium fortuitum.阿米卡星、红霉素和强力霉素对龟分枝杆菌和偶然分枝杆菌的活性。
Tubercle. 1978 Dec;59(4):277-80. doi: 10.1016/0041-3879(78)90005-3.
5
In vitro susceptiiblity of Mycobacterium fortuitum and Mycobacterium chelonei to amikacin.偶然分枝杆菌和龟分枝杆菌对阿米卡星的体外敏感性
J Infect Dis. 1978 Mar;137(3):318-21. doi: 10.1093/infdis/137.3.318.
6
Antimicrobial susceptibility testing of Mycobacterium fortuitum complex.偶然分枝杆菌复合体的药敏试验
Antimicrob Agents Chemother. 1979 Jun;15(6):754-7. doi: 10.1128/AAC.15.6.754.